ADORA2A and neoplasm: DOX-induced ICD triggeredthe release of tumor neoantigens to improve tumor immunogenicity.Significantly, by blocking the binding of adenosine to A2AR on thesurface of various TIICs (e.g., Tregs), SCH58261 reversed the immunosuppressiveTMME to enhance DOX-induced ICD.